Central Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 16, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Market Capitalization	1,246	2,168	1,486	1,569	1,581	1,593	Upgrade
Market Cap Growth	-5.31%	45.97%	-5.34%	-0.76%	-0.75%	5.56%	Upgrade
Enterprise Value	1,513	2,454	1,752	1,818	1,803	1,818	Upgrade
Last Close Price	10.40	18.10	12.40	13.10	13.20	13.30	Upgrade
PS Ratio	177.51	73.26	50.65	60.37	10.67	11.37	Upgrade
PB Ratio	1.47	2.57	2.22	2.20	2.02	2.02	Upgrade
P/TBV Ratio	1.47	2.57	2.22	2.20	2.02	2.02	Upgrade
P/FCF Ratio	-	731.27	-	-	-	-	Upgrade
P/OCF Ratio	507.11	731.27	-	-	880.40	-	Upgrade
EV/Sales Ratio	215.58	82.90	59.75	69.92	12.17	12.97	Upgrade
EV/EBITDA Ratio	-	-	-	-	45.42	-	Upgrade
EV/EBIT Ratio	-	-	-	-	264.59	-	Upgrade
EV/FCF Ratio	-	827.53	-	-	-	-	Upgrade
Debt / Equity Ratio	0.32	0.32	0.40	0.38	0.32	0.29	Upgrade
Debt / EBITDA Ratio	-	-	-	-	6.33	-	Upgrade
Debt / FCF Ratio	109.27	90.64	-	-	-	-	Upgrade
Asset Turnover	0.01	0.02	0.02	0.02	0.11	0.07	Upgrade
Inventory Turnover	1.25	2.55	1.90	1.26	2.06	1.95	Upgrade
Quick Ratio	0.22	0.23	0.25	0.25	0.26	0.20	Upgrade
Current Ratio	1.15	1.14	1.18	1.25	1.37	1.31	Upgrade
Return on Equity (ROE)	-4.82%	-5.60%	-6.35%	-9.12%	-1.08%	-86.06%	Upgrade
Return on Assets (ROA)	-1.78%	-1.74%	-2.32%	-2.49%	0.31%	-35.91%	Upgrade
Return on Capital (ROIC)	-2.34%	-2.30%	-3.12%	-3.31%	0.42%	-45.76%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	0.60%	-	Upgrade
Earnings Yield	-291.83%	-1.96%	-2.96%	-4.35%	-0.54%	-69.48%	Upgrade
FCF Yield	-	0.14%	-0.02%	-0.07%	-0.30%	-0.03%	Upgrade
Buyback Yield / Dilution	129.00%	-	-	-	-	-	Upgrade
Total Shareholder Return	129.00%	-	-	-	-	-	Upgrade

Updated Dec 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.